US News Pulse Newsroom
Editorial Team
Published : Nov 17, 2026
Online Edition

L'Oreal Hair Relaxer Cancer Cases Settle During Chicago Trial - US News Pulse

L'Oreal Hair Relaxer Cancer Cases Settle During Chicago Trial - US News Pulse

L'Oreal's US arm has settled the first hair relaxer cancer cases ever to reach trial, ending a Chicago courtroom test watched as a bellwether for a mass legal fight now covering more than 12,700 claims. Four women who said chemical hair straighteners left them with gynaecologic cancers settled on Monday, November 16, 2026, with L'Oreal USA and other companies, their attorneys said, one week after jury selection began.

The deal resolves only the four cases that were before the court. It leaves untouched the thousands of claims consolidated in federal court in Chicago, where the first verdicts could still set the price of every settlement that follows.

Key Points

  • Four women — MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson — settled with L'Oreal USA and other defendants during the first hair relaxer trial, for a confidential sum.
  • The women sued in Cook County, Illinois, in 2023 and 2024. The trial began on November 9, 2026, with jury selection.
  • More than 12,700 cases over the claims are centralised before a judge in federal court in Chicago, court records show.
  • The women allege that years of using chemical straighteners — sold as Dark and Lovely, Optimum and SoftSheen-Carson — caused them to develop gynaecologic cancers.
  • The lawsuits followed a 2022 National Institutes of Health study linking frequent use of the products to more than double the risk of uterine cancer. L'Oreal says the study did not establish a causal link.

What Happened

The four women sued in Cook County, Illinois, in 2023 and 2024, and their cases were the first in the hair relaxer litigation to be tried before a jury. Jury selection began on November 9, and the settlement was reached on Monday, November 16, according to the women's attorneys. The amount was not disclosed.

The defendants included L'Oreal's US subsidiary and several other makers of the products. The settlement ends the Chicago trial, but not the litigation: thousands of similar claims remain pending, most consolidated in a single federal case in Chicago.

At least two states have also acted this year. Arizona and Minnesota have sued L'Oreal over the products, alleging the company misled women about their safety — a second front in a fight so far driven by private lawsuits.

Background: The 2022 Study That Started the Lawsuits

The first lawsuits followed the 2022 release of a National Institutes of Health study, which found that women who used chemical hair straightening products several times a year were more than twice as likely to develop uterine cancer as women who did not use them. The finding landed with force because the products are used so widely and have been marketed for decades as routine hair care.

The products at the centre of the cases promise to permanently straighten textured hair. They have been sold under names including Dark and Lovely, Optimum and SoftSheen-Carson, and marketed to Black women. For many users, the products were a regular purchase over years, and the lawsuits argue that the long, repeated exposure is what matters.

L'Oreal has consistently disputed the link. The company has said the study did not establish a causal link between the use of the products and any of the conditions alleged by the plaintiffs. That dispute — between an observed association in a large study and proof of cause in a courtroom — is the scientific question at the heart of the litigation.

The L'Oreal Hair Relaxer Settlement: What It Means for 12,700 Cases

A settlement in the first case to reach trial is a milestone, but it is not a verdict. Because the sum is confidential, the deal gives no public signal about how the companies value the remaining claims, and it creates no legal precedent. What it does show is that, with a jury seated, both sides saw more risk in continuing than in settling.

For the women who settled, the deal ends a case that began with filings in 2023 and 2024. For the more than 12,700 plaintiffs in federal court in Chicago, it changes little: their claims will still be tested through bellwether trials, and a single verdict could reshape the settlement value of the rest.

Reactions: What Both Sides Said

A L'Oreal spokesperson said the company's highest priority is the health and wellbeing of its consumers, and that it remains confident in the safety of its SoftSheen-Carson hair products, which include hair relaxers. “L'Oréal USA strictly follows all regulations in every market in which it operates, and its products are always subject to a rigorous scientific evaluation of their safety,” the spokesperson said.

Danielle Ward Mason, an attorney for the four women, said she hoped the settlement would give the women a sense of justice. The attorneys announced the settlement on Monday, but did not disclose its terms.

Why It Matters

The case matters first because of who used these products. Chemical straighteners were marketed heavily to Black women, and the women bringing the claims say they used the products for years. If the science holds up in court, the health consequences will fall on a group that has historically had less power to demand answers from the companies selling to them.

It also matters for the regulation of everyday products. Hair relaxers sit on store shelves alongside ordinary cosmetics, yet the claims against them involve serious cancers. Cancer screening guidance keeps evolving as new evidence emerges, and these cases are part of a wider argument about how much evidence should be needed before a product's safety is questioned.

What Happens Next

The federal cases in Chicago move on. The court overseeing more than 12,700 claims will continue preparing bellwether trials, and the state lawsuits in Arizona and Minnesota will proceed on their own timetables. Large court-ordered payments in health cases are not new — a Washington judge recently ordered a $900 million opioid verdict.

L'Oreal maintains that its products are safe and that it follows all regulations. The companies have not said whether they expect to settle more cases or fight the next trials to a verdict. The next test will come when a jury is finally asked to decide whether the products caused cancer.

Read more on US health news: US set to lose measles elimination status after 25 years as PAHO review nears.

Frequently Asked Questions

What did L'Oreal settle?
L'Oreal USA and other companies settled the first four hair relaxer cancer cases to reach trial, brought by four women in Cook County, Illinois, on November 16, 2026, for a confidential sum.

How many hair relaxer lawsuits are there?
More than 12,700 cases over the claims are centralised before a judge in federal court in Chicago, according to court records.

Which products are named in the lawsuits?
Dark and Lovely, Optimum and SoftSheen-Carson, widely marketed to Black women.

What did the 2022 NIH study find?
It found women who used the products several times a year were more than twice as likely to develop uterine cancer. L'Oreal says the study did not establish a causal link.

Does the settlement mean L'Oreal admitted fault?
No admission of fault has been reported; the terms are confidential, and L'Oreal says it remains confident in the safety of its products.

US News Pulse
Written by
US News Pulse Newsroom
Editorial Team

The US News Pulse newsroom covers breaking news across the United States and the world, working from wire services, official statements and on-the-record sources. Every story is reviewed against our editorial standards before publication. Corrections and tips: info@usnewspulse.com

About our newsroom

Leave a Comment

  • Latest
  • Popular

LaKesha Womack Faces Felony Court Date Nov 10 After North Ca

1

Deb Haaland gana en Nuevo México en un triunfo histórico par

2

Amish Shah Makes History as First Indian-American to Represe

3

Florida and Texas Set Executions for Thursday as Florida Nea

4

Microsoft AI Frontiers Is Over as Leader John Langford Quits

5

Abu Dhabi Peace Talks End Day One With Gaps Narrowed but Don

6

Biden y Pelosi se reconcilian con un almuerzo italiano, segú

7

Ataque de oso grizzly en Bella Coola mata a madre e hija en

8

Prueba nacional de alerta de emergencia hoy: solo TV y radio

9

Trump afirma que ningún soldado murió en cinco meses de guer

10

Two DeKalb Officers Shot Responding to Domestic Call, Suspec

11

Democrats Win Senate Control in 2026 Midterms, Completing Co

12

Estados del Golfo se Preparan para Investigaciones Demócrata

13

Jueza frena la reforma del campo de golf East Potomac de Tru

14

Binance CFO Kaiser Ng Steps Down a Week After $6.3 Billion H

15

Rubio gastó 1,2 millones de los contribuyentes en vuelos mil

16

Jameneí advierte que la guerra será 'mucho más amplia' si EE

17

Thomas Markle Jailed Without Bond After Cutting Off Ankle Mo

18

Ohio State Beats Northwestern 28-19 to Snap Two-Game Skid an

19

Brooklyn Collapse Death Toll Rises to 8 as FDNY Search Conti

20